July 23, 2021 General information Some COVID-19 myths that refuse to die come with important caveats. With time, some of them become accepted facts with supporting evidence, others become misinformation that are difficult to dislodge. #vaccineswork
July 14, 2021 Health Policy Western University tattoo ink study reveals many products did not have sterility, lot numbers, manufacturer names, expiration instructions, and quality control of ingredients on their labels. Canada has “absolutely nothing” in terms of regulation.
June 28, 2021 Health Policy Immunocompromised people need our help to protect them from Covid infection. Although many have been vaccinated, many do not produce a sufficient immune response. Please step up, take a world view, and help others by deciding to get the vaccine.
June 24, 2021 Health Policy Thoughts now turn to policies to protect children so they can safely return to school in the fall especially if vaccines have yet to be approved for their age group.
June 21, 2021 Health Policy I have recommended to my wife and two adult sons to opt for Moderna after receiving 1sr dose of Pfizer (unavailable this week). Mixing works and it is safe to do so. End result = protection #vaccineswork #protectyourfamilywithscience
June 18, 2021 Health Policy NACI now recommends “preferred” interchangeable Pfizer & Moderna as second dose after first AZ vaccine. Correct decision but NACI’s less-than-stellar messaging trend has contributed to understandable AZ recipients and providers’ frustration.
June 14, 2021 Allergy/Immunology What should your #seconddose of #covidvaccine be if 1st was AZ? Factors include wait-time/availability, Delta variant prevalence, occupational risks, and study evidence. Answer seems to leaning to Pfizer or Moderna as 2nd dose of choice.
June 10, 2021 Health Policy Ontario Medical Association estimates that there is a backlog 16 million medical services including mental health support, surgeries, cancer screening, monitoring of chronic disease, MRIs, and CT scans amongst the myriad of other services.
June 8, 2021 Health Policy FDA approval process questioned as it approves new early-stage $56K US/year treatment for Alzheimer’s despite its own panel founding insufficient evidence of efficacy. Only when company changed the study endpoint did it show efficacy compared to placebo.
June 4, 2021 Allergy/Immunology Pfizer vaccine recipients have lower neutralizing antibodies targeting delta variant up to three months after first dose. Outcome data needed to determine if this translates into less efficacy. Study concludes second dose interval needs to be shortened.
